Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.

Acta neuropathologica - 1 May 2015

Walker Lauren, McAleese Kirsty E, Thomas Alan J, Johnson Mary, Martin-Ruiz Carmen, Parker Craig, Colloby Sean J, Jellinger Kurt, Attems Johannes

Abstract excerpt

Multiple different pathological protein aggregates are frequently seen in human postmortem brains and hence mixed pathology is common. Mixed dementia on the other hand is less frequent and neuropathologically should only be diagnosed if criteria for more than one full blown disease are met. We qu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Amyloid beta-Peptides
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dementia

Share to Lewy Body Disease

Share to Microtubule-Associated Proteins

Share to Protein Aggregates

Share to tau Proteins

Source

Identifiers

PMID: 25758940
DOI: 10.1007/s00401-015-1406-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25758940-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.PMID 25758940Read ↗

Alzheimer’s disease copathology in dementia with Lewy bodies is associated with astroglial α-synucleinopathySemantic proximity Read ↗

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers.Semantic proximity Read ↗

β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.Semantic proximity Read ↗

Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.Semantic proximity Read ↗

Comorbid neuropathological diagnoses in early vs late-onset Alzheimer’s diseaseSemantic proximity Read ↗

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal DementiasSemantic proximity Read ↗

Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathologySemantic proximity Read ↗

In vivo PET classification of tau pathologies in patients with frontotemporal dementiaSemantic proximity Read ↗

Co-occurrence of multiple pathologies in a case of frontotemporal dementia with TBK1 mutation: first in vivo detection of alpha-synuclein and tau co-pathology.Semantic proximity Read ↗

Dementia with Lewy bodies.Semantic proximity Read ↗

Alpha-synuclein deposition patterns in Alzheimer’s disease: association with cortical amyloid beta and variable tau loadSemantic proximity Read ↗

Associations between misfolded alpha‐synuclein aggregates and Alzheimer's disease pathology in vivoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.